Law M R, Wald N J, Wu T, Hackshaw A, Bailey A
Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's Hospital Medical College, London.
BMJ. 1994 Feb 5;308(6925):363-6. doi: 10.1136/bmj.308.6925.363.
To estimate the size of the association between serum concentration of low density lipoprotein cholesterol and mortality from ischaemic heart disease.
Prospective study of total serum cholesterol concentration and mortality from ischaemic heart disease in 21,515 men (538 deaths) and study of total cholesterol concentration measured on two occasions an average of three years apart in 5696 men in whom low density lipoprotein cholesterol concentration was also measured on the second occasion.
Men who attended the medical centre of the British United Provident Association (BUPA) in London between 1975 and 1982.
The difference in mortality from ischaemic heart disease for a 0.6 mmol/l difference in concentration of low density lipoprotein cholesterol after adjustment for, firstly, regression dilution bias, which arises from the random fluctuation of serum cholesterol concentration in people over time, and, secondly, the surrogate dilution effect, which arises because differences in total cholesterol concentration between people reflect smaller differences in low density lipoprotein cholesterol concentration.
The observed difference in mortality from ischaemic heart disease associated with a difference of 0.6 mmol/l in total serum cholesterol concentration was 17% but increased to 24% after correction for the regression dilution bias and to 27% (95% confidence interval 21% to 33%) after adjustment for both sources of underestimation, which provides an estimate of the difference in mortality for a true difference of 0.6 mmol/l in low density lipoprotein cholesterol concentration. The association was greater at younger ages. The estimated decrease in mortality from all causes was 6% before and 10% (1% to 17%) after adjustment for the two sources of underestimation. There was no excess mortality from any cause associated with low cholesterol concentration.
The association between serum cholesterol concentration and ischaemic heart disease is materially stronger than directly inferred from prospective studies. This has important implications for the health benefit of achieving low cholesterol concentrations.
评估低密度脂蛋白胆固醇血清浓度与缺血性心脏病死亡率之间的关联程度。
对21515名男性(538例死亡)的血清总胆固醇浓度和缺血性心脏病死亡率进行前瞻性研究,并对5696名男性进行研究,他们在平均相隔三年的两个时间点测量了总胆固醇浓度,且在第二次测量时还测量了低密度脂蛋白胆固醇浓度。
1975年至1982年间在伦敦英国联合 Provident 协会(BUPA)医疗中心就诊的男性。
首先校正回归稀释偏倚(其源于人群血清胆固醇浓度随时间的随机波动),其次校正替代稀释效应(其源于人群总胆固醇浓度差异反映的低密度脂蛋白胆固醇浓度差异较小)后,低密度脂蛋白胆固醇浓度每相差0.6 mmol/l时缺血性心脏病死亡率的差异。
观察到血清总胆固醇浓度相差0.6 mmol/l时,缺血性心脏病死亡率的差异为17%,校正回归稀释偏倚后增至24%,校正两种低估来源后增至27%(95%置信区间21%至33%),这提供了低密度脂蛋白胆固醇浓度真正相差0.6 mmol/l时死亡率差异的估计值。该关联在较年轻年龄段更大。校正两种低估来源前,所有原因导致的死亡率估计降低6%,校正后为10%(1%至17%)。低胆固醇浓度未导致任何原因的额外死亡率。
血清胆固醇浓度与缺血性心脏病之间的关联比前瞻性研究所直接推断的要强得多。这对实现低胆固醇浓度的健康益处具有重要意义。